Yukti Pharma Private Limited
About Yukti Pharma Private Limited
Data last updated:
Yukti Pharma Private Limited is a private limited company based in Haryana, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 22 December 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U51397HR2003PTC035268.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Nisha Rani (Whole-Time Director) and Ankur Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 14 Ashok Viharambala Cantt, Haryana, India – 133001.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.22 Lakh, a decline of 37% compared to the previous year. For the same year it recorded a net profit of ₹20,669 (net margin 0.6%) and EBITDA of ₹31,261 (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 12% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Yukti Pharma Private Limited's registered office is in Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address14 Ashok Viharambala Cantt, Haryana, India – 133001
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Yukti Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Yukti Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Yukti Pharma Private Limited, buy the company report.
Financials of Yukti Pharma Private Limited
FY 2025 filings availableYukti Pharma Private Limited reported revenue of ₹36.22 Lakh (down 37% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 37% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 12%. EBITDA fell 72% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹31,261 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹20,669 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Yukti Pharma Private Limited, buy the company report.
Board of directors of Yukti Pharma Private Limited
Yukti Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankur Aggarwal | Director | 21 Feb 2015 | 11 Years 8 Months | Current |
| Yukti Vinod Aggarwal | Director | 22 Dec 2003 | 22 Years 10 Months | Current |
| Nisha Rani | Whole-Time Director | 22 Dec 2003 | 22 Years 10 Months | Current |
Peer comparison
Yukti Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Turant Global Impex Private Limited | ₹36.22 Lakh (FY 2024) | 1063.0% | Noida, Uttar Pradesh, India | |||
| Dhiraj Organic Foods Private Limited | ₹36.22 Lakh (FY 2018) | -56.0% | Sri Ganganagar, Rajasthan, India | |||
| Gee Dee Fats Private Limited | ₹36.22 Lakh (FY 2023) | -68.0% | Abohar, Punjab, India | |||
| Acorn Infracon Private Limited | ₹36.22 Lakh (FY 2025) | -42.0% | Kolkata, West Bengal, India | |||
| Gojital Private Limited | ₹36.22 Lakh (FY 2024) | -95.0% | Delhi, India | |||
| Yukti Pharma Private Limitedthis company | ₹36.22 Lakh (FY 2025) | ₹20,669 | 0.6% | -37.0% | Haryana, India | |
| Midnight Commodities Private Limited | ₹36.22 Lakh (FY 2017) | 19.0% | Kolkata, West Bengal, India | |||
| Catena Technologies Private Limited | ₹36.21 Lakh (FY 2019) | -33.0% | Bangalore, Karnataka, India | |||
| Solsun Lifecare Private Limited | ₹36.21 Lakh (FY 2022) | -19.0% | Mumbai, Maharashtra, India | |||
| Teknovision Private Limited | ₹36.21 Lakh (FY 2025) | -67.0% | Mumbai, Maharashtra, India | |||
| Poblic Traders Private Limited | ₹36.21 Lakh (FY 2025) | 134.0% | Delhi, India |
To see the full peer comparison of Yukti Pharma Private Limited, buy the company report.
Auditor
Yukti Pharma Private Limited is audited by A.K SOOD AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A.K SOOD AND ASSOCIATES | FY 2017 | 000072N |
Shareholding
The shareholding of Yukti Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Yukti Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Yukti Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Yukti Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Yukti Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Yukti Pharma Private Limited has 5 board changes on record since 2003: 3 appointments and 2 cessations. The latest: Ankur Aggarwal ceased to be Additional Director on 30 Sep 2015.
Frequently asked questions
Yukti Pharma is an active private limited company based in Haryana, India. The company works in other wholesale, within the trading industry. It was incorporated on 22 December 2003 (23+ years old) and is registered under CIN U51397HR2003PTC035268.
Yukti Pharma has 3 current directors:
- Nisha Rani - Whole-Time Director
- Ankur Aggarwal - Director
- Yukti Vinod Aggarwal - Director
The latest financial statements of Yukti Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Yukti Pharma is U51397HR2003PTC035268. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yukti Pharma was incorporated on 22 December 2003, making it 23+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Yukti Pharma by revenue are Turant Global Impex Private Limited, Dhiraj Organic Foods Private Limited, Gee Dee Fats Private Limited, Acorn Infracon Private Limited, Gojital Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Ankur Aggarwal ceased to be Additional Director on 30 Sep 2015. Ankur Aggarwal was appointed as Director on 21 Feb 2015. Nisha Rani ceased to be Director on 21 Feb 2015. Yukti Pharma has 5 board changes on record in total.
The registered office of Yukti Pharma is at 14 Ashok Viharambala Cantt, Haryana, India – 133001.
Yukti Pharma operates in the trading industry, in the other wholesale segment.
The compliance status of Yukti Pharma is compliant as of 28 August 2026. The company is actively filing with the Registrar of Companies.
Yukti Pharma can be reached at its registered office: 14 Ashok Viharambala Cantt, Haryana, India – 133001.